Accelerated Wound Healing by ]Recombinant Human Basic Fibroblast Growth Factor in Healing-impaired Animal Models

  • Kang, Soo-Hyung (Research Laboratories, Dong-A Pharmaceutical Co, Ltd.) ;
  • Oh, Tae-Young (Research Laboratories, Dong-A Pharmaceutical Co, Ltd.) ;
  • Cho, Hyun (Research Laboratories, Dong-A Pharmaceutical Co, Ltd.) ;
  • Ahn, Byoung-Ok (Research Laboratories, Dong-A Pharmaceutical Co, Ltd.) ;
  • Kim,Won-Bae (Research Laboratories, Dong-A Pharmaceutical Co, Ltd.)
  • 발행 : 1999.03.01

초록

The stimulatory effect of recombinant human basic fibroblast growth factor (bFGF) on wound healing was evaluated in healing-impaired animal models. Full-thickness wounds were made in prednisolone-treated mice, streptozotocin (STZ)-induced diabetic rats and mitomycin C (MMC)-treated rats. Saline or bFGF at a dose of 1, 5, or $25\mu\textrm{g}$ per wound was applied to the open wound once a day for three to five days. The degree of wound healing was assessed using wound size and histological parameters such as degree of epidermal and dermal regeneration. Local application of bFGF accelerated wound closure significantly in a dose-dependent manner in all healing-impaired wounds (p<0.05). The wound healing effect of bFGF was further confirmed by histological examination in MMC-treated rats. Epidermal and dermal regeneration were enhanced in bFGF-treated wounds with a dose-related response. Dermal regeneration parameters such as collagen matrix formation and angiogenesis were significantly increased in $5\mu\textrm{g}$, or $\25mu\textrm{g}$ of bFGF-treated wounds when compared to saline-treated wounds (p<0.05). pectin immunostaining on day 8 for vascular endothelium showed an increased number of neovessels in bFGF-treated wounds. These results suggest that topical application of bFGF has beneficial effects on wound healing by angiogenesis and granulation tissue formation in healing-impaired wounds.

키워드